Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-07-05
1998-01-06
Jagannathan, Vasu S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 8, 514 12, 514 21, 514886, 530399, 424 851, A61K 3818, C07K 14495
Patent
active
057054770
ABSTRACT:
A composition for the promotion of cell proliferation and tissue repair in animals having as active ingredients a TGF-.beta. which is activated by either a TGF-.alpha. or an EGF or both; and methods for administration. As another embodiment these active ingredients can be admixed with other (secondary) growth factors.
REFERENCES:
patent: 3409605 (1968-11-01), Florini
patent: 3699222 (1972-10-01), Isaacs et al.
patent: 4054557 (1977-10-01), Sievertsson et al.
patent: 4341765 (1982-07-01), Ruchenstroth-Bauer et al.
patent: 4350687 (1982-09-01), Lipton et al.
patent: 4479896 (1984-10-01), Antoniades
patent: 4686283 (1987-08-01), Nestor, Jr. et al.
patent: 4708948 (1987-11-01), Iwata et al.
patent: 4742002 (1988-05-01), Guadagno
patent: 4742003 (1988-05-01), Derynck et al.
patent: 4774322 (1988-09-01), Seyedin et al.
patent: 4816442 (1989-03-01), McPherson et al.
patent: 4816561 (1989-03-01), Todaro
patent: 4843063 (1989-06-01), Seyedin et al.
American Society of Biological Chemists, 74th Annual Meeting Abstract Nos. 419, 420, 428, 430, 439, 440 and 853, San Francisco, CA (Jun. 5-9, 1983).
Anzano et al, Proceedings of the First International Symposium, Hearn et al, ed., pp. 111-118 (Jan. 28, 1983).
Anzano et al, International Symposium HPLC Protein Peptide, #505, p. 25 (1981).
Brewer et al, Experimental Techniques in Biochemistry, p. 52 (1974).
Childs et al, Chemical Abstracts 97:142402j (1982).
De Larco et al, Journal of Cellular Physiology, 109:143-152 (1981).
Dicker et al, Chemical Abstracts, 95:201393r (1981).
Frolik et al, Biological Abstracts, 25:45382 (1983).
Massague, The Journal of Biological Chemistry, vol. 258, No. 22, pp. 13614-13620 (1983).
Moses et al, Cancer Research, vol. 41, pp. 2842-2848 (Jul. 1981).
Moses et al, Eur. J. Biochem., vol. 103, pp. 387-400 (1980).
Sporn et al, The New England Journal of Medicine, vol. 303, No. 15, pp. 878-880 (Oct. 9, 1980).
Niall et al, Journal of Surgical Research, vol. 33, pp. 164-169 (1982).
Stark et al, The Journal of Biological Chemistry, vol. 235, No. 11, pp. 3177-3181 (Nov. 1960).
Stromberg et al, Biochemical and Biophysical Research Communications, vol. 106, No. 2, pp. 354-361 (May 31, 1982).
Todaro et al, Proc. Natl. Acad. Sci. USA, vol. 77, No. 9, pp. 5258-5262 (Sep. 1980).
Twardzik et al, JNCI, vol. 69, No. 4, pp. 793-798 (Oct. 1982).
"Ion Exchange Chromatography", Pharmacia Fine Chemicals Brochure, pp. 43-47 and 61 (Mar. 1980).
"Gel Filtration Theory and Practice", Pharmacia Fine Chemicals Brochure, p. 44 (Mar. 1980).
Marshall et al, Practical Protein Chemistry A Handbook, Edited by Darbre, pp. 18-19 (1986).
A.B. Roberts, et al., Nature (1982), 295:417-419, Macmillan Journals Ltd., U.S.
Anzano et al. Cancer Res., (1982) 42(11), 4776-8.
Assoian et al., Federation Proceedings (USA) 42(7)1831 Abstract 428 (1983).
Frolik et al., PNAS, 80(12):3676-3680 (1983).
Assoian et al., Journal of Biological Chemistry 258 (11):7155-7160 (1983).
Roberts et al., Federation Proceedings vol. 42(7):1832, abstract 439 (1983).
Noe et al., Hormone Metab.Res. 7:314-22 (1975).
Permutt et al., J. Clin. Endocrin. Metab. 44:536-44 (1977).
Sporn et al., Science 219:1329-31 (1983).
Anzano et al, Federation Proceedings, vol. 40, No. 6, p. 1643, Abstract No. 598 (May 1, 1981).
Sporn et al, Federation Proceedings, vol. 41, No. 5, Abstract No. 1288 (Mar. 5, 1982).
Roberts et al, PNAS USA, 78, No. 9, pp. 5339-5343 (Sep. 1981).
Frolik et al, Analytical Biochemistry, 125:203-209 (1982).
Todaro et al, Journal of Supramolecular Structure and Cellular Biochemistry, 15:287-301 (1981).
Anzano et al, Proc. of the First Intl. Sym. on HPLC of Proteins and Peptides, Washington, D.C., Nov. 16-17, 1981, Abstract No. 505.
Childs et al, PNAS USA, 79:5312-5316 (Sep. 1982).
Anzano et al, Analytical Biochemistry, 125, 217-224 (1982).
Brown et al, Proc. Natl. Acad. Sci. USA, 84, 3743-3747 (1987).
DeLarco et al, Proc. Natl. Acad. Sci. USA, 75, No. 8, 4001-4005 (1978).
DeLarco et al, Nature, 272, 356-358 (1978).
Holley et al, Proc. Natl. Acad. Sci. USA, 77, No. 10, 5989-5992 (1980).
Massague et al, The Journal of Biological Chemistry, 260, 4551-4554 (1985).
Marquardt et al, The Journal of Biological Chemistry, 255, No. 19, 9177-9181 (1980).
Marquardt et al, The Journal of Biological Chemistry, 256, No. 13, 6859-6862 (1981).
Moses et al, Oncogenes and Growth Control, Edited by P. Kahn and T. Graf, 50-56 (1986).
Moses et al, Cancer Research, 41, 2842-2848 (1981).
Todaro et al, Cancer Research, 38, 4147-4154 (1978).
Tucker et al, Cancer Research, 43, 1581-1586 (1983).
Kovacina et al, Biochemical and Biophysical Research Communications, vol. 160, No. 1, pp. 393-403 (1989).
Todaro et al, PNAS, vol. 77, pp. 5258-5262 (1980).
Roberts et al, PNAS, vol. 77, pp. 3494-3498 (1980).
Carrico et al, Surgical Clinics of North America, vol. 64(4) 1984, pp. 121-133.
Abstracts of the 20th Annual Meeting on Wound Repair, J. Cellular Biochem, Suppl 15F, 1991, pp. 159-169 (varies).
Roberts Anita B.
Sporn Michael B.
Jagannathan Vasu S.
Saoud Christine
The United States of America as represented by the Department of
LandOfFree
Compositions of transforming growth factor .beta.(TGF-.beta.) wh does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions of transforming growth factor .beta.(TGF-.beta.) wh, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions of transforming growth factor .beta.(TGF-.beta.) wh will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2329196